Loading stock data…
$0.35-0.00 (-1.30%)
cbdMD, Inc.
cbdMD, Inc. in the Healthcare sector is trading at $0.35 with a market capitalization of $5M. The stock is currently near its 52-week low of $0.33, remaining 50.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 18 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.55M↓ | $5.64M↑ | $5.02M↑ | $4.72M↑ | $4.61M |
| Gross Profit | $3.04M↓ | $3.26M↑ | $3.00M↑ | $2.78M↓ | $2.83M |
| Operating Income | -$1.13M↓ | -$800,784↓ | -$286,288↑ | -$685,816↑ | -$904,686 |
| Net Income | -$1.13M↓ | -$797,978↓ | -$283,131↑ | -$679,968↑ | -$895,272 |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gel...